REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA

Clinical trials for REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough leukemias: targeted pill shows promise in Late-Stage trial

Disease control Ongoing

This study tested a daily pill called ibrutinib in 154 people with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or B-cell prolymphocytic leukemia (B-PLL) that had come back or stopped responding to prior treatments. The goal was to see if the drug could c…

Matched conditions: REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA

Phase: PHASE2 • Sponsor: Kami Maddocks, MD • Aim: Disease control

Last updated May 17, 2026 07:32 UTC

REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA

Get alerted when new REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA trials appear

New hope for tough leukemias: targeted pill shows promise in Late-Stage trial